\-\ Texto\\:\\ \ \(0\)\
\-\ back\\:\\ mild\\ tenderness\\ to\\ palpation\\ over\\ lower\\ thoracic\\/upper\\ lumbar\\ spine\\.\\ \ \(0\)\
\-\ csf\\:\\ lp\\ opening\\ pressure\\:\\ 18\\ cm\\ h2o\\,\\ wbc\\=32\\,rbc\\=2\\,\\ glc\\=53\\,\\ prtn\\=92\\ 76\\%lymphs\\.\\ gram\\ stain\\:\\ pmns\\ present\\.\\ no\\ organisms\\.\\ \ \(0\)\
\-\ cbc\\:\\ 5\\.68\\>10\\.6\\/31\\.6\\<443\\ \ \(0\)\
\-\ cmp\\:\\ 140\\/4\\.4\\/99\\/29\\/11\\/0\\.5\\<95\\,\\ ca\\ 9\\.6\\,\\ po4\\ 4\\.8\\,\\ mg\\ 1\\.6\ \(0\)\
\-\ pt\\ started\\ on\\ 6\\ week\\ course\\ of\\ florquinalone\\ antibiotic\\ therapy\\ and\\ discharged\\ to\\ outpatient\\ care\\ with\\ a\\ back\\ brace\\.\ \(0\)\
\-\ plain\\ radiograph\\ one\\ week\\ later\\ showed\\ decreased\\ disk\\ space\\ between\\ t10\\-t11\\ \ \(0\)\
\-\ on\\ fat\\-suppressed\\ mri\\ \\(stir\\ and\\ fse\\ t2\\-weighted\\ with\\ fat\\ sat\\ mri\\)\\,\\ high\\-signal\\ \\-ntensity\\ mass\\ anterior\\ to\\ thoracic\\ vertebrae\\,\\ high\\ signal\\ intensity\\ in\\ the\\ disc\\ space\\ and\\ in\\ the\\ thoracic\\ vertebrae\\ at\\ this\\ level\\ are\\ consistent\\ with\\ infection\\.\\ these\\ areas\\ enhance\\ after\\ contrast\\ on\\ the\\ contrast\\-enhanced\\ fat\\-saturated\\ \\ t1\\-weighted\\ mr\\ images\\.\ \(0\)\
\-\ citrobacter\\ koseri\\ osteomyelitis\\/discitis\ \(0\)\
\-\ 1\\.\\ discitis\\/osteomyelitis\\ \ \(0\)\
\-\ 2\\.\\ pott\\'s\\ disease\\ \ \(0\)\
\-\ 3\\.\\ djd\\ \ \(0\)\
\-\ 4\\.\\ metastatic\\ cancer\ \(0\)\
\-\ 52\\ y\\/o\\ aa\\ male\\ recently\\ deployed\\ soldier\\ who\\ was\\ medically\\ evacuated\\ due\\ to\\ chronic\\ back\\ pain\\ that\\ interfered\\ with\\ his\\ duties\\ as\\ a\\ truckdriver\\.\\ while\\ being\\ evaluated\\ stateside\\ his\\ pain\\ worsened\\ and\\ he\\ developed\\ altered\\ mental\\ status\\,\\ prompting\\ a\\ lumbar\\ puncture\\ which\\ revealed\\ signs\\ consistent\\ with\\ a\\ potential\\ infection\\.\\ an\\ mri\\ was\\ then\\ obtained\\ for\\ further\\ evalutaion\\.\ \(0\)\
\-\ the\\ specific\\ cause\\ or\\ underlying\\ condition\\ leading\\ to\\ the\\ development\\ of\\ discitis\\ in\\ this\\ patient\\ is\\ unclear\\.\\ \\ most\\ cases\\ of\\ discitis\\ show\\ increased\\ signal\\ intensity\\ on\\ t2wi\\ mri\\ within\\ 48\\ hours\\ of\\ presentation\\ and\\ the\\ course\\ of\\ infection\\ typically\\ moves\\ anterior\\ to\\ posterior\\ as\\ seen\\ with\\ this\\ patient\\,\\ ultimately\\ moving\\ posterior\\ until\\ the\\ spinal\\ cord\\ was\\ involved\\.\ \(0\)\
\-\ the\\ diagnosis\\ of\\ pott\\'s\\ disease\\ was\\ considered\\ in\\ the\\ differential\\ diagnosis\\;\\ however\\,\\ the\\ unremarable\\ ct\\ obtained\\ one\\ month\\ prior\\ suggests\\ against\\ a\\ tuberculosis\\ infection\\ due\\ to\\ the\\ historically\\ slower\\ progression\\ of\\ disease\\ seen\\ with\\ pott\\'s\\.\\ \\ \ \(0\)\
\-\ metastatic\\ bone\\ lesions\\ were\\ also\\ considered\\;\\ however\\,\\ were\\ less\\ likely\\ due\\ to\\ the\\ rare\\ incidence\\ of\\ intramedullary\\ involvement\\ and\\ the\\ involvement\\ of\\ the\\ disc\\ space\\.\ \(0\)\
\-\ mri\\ is\\ considered\\ the\\ best\\ method\\ for\\ diagnosing\\ disc\\ space\\ infection\\ with\\ a\\ sensitivity\\ of\\ 96\\%\\ and\\ a\\ specificity\\ of\\ 94\\%\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ pott\\:\\ 0\\.051204440035915906\ \(0\)\
\-\ discitis\\:\\ 0\\.04104737306009781\ \(0\)\
\-\ infection\\:\\ 0\\.03303213529352137\ \(0\)\
\-\ disc\\:\\ 0\\.03174922752937516\ \(0\)\
\-\ space\\:\\ 0\\.030069755394432282\ \(0\)\
\-\ considered\\:\\ 0\\.027522944752217924\ \(0\)\
\-\ vertebrae\\:\\ 0\\.02618988364816953\ \(0\)\
\-\ mri\\:\\ 0\\.026107391687694412\ \(0\)\
\-\ florquinalone\\:\\ 0\\.023445527723315155\ \(0\)\
\-\ \\-ntensity\\:\\ 0\\.023445527723315155\ \(0\)\
\-\ back\\:\\ 0\\.02249255054798519\ \(0\)\
\-\ thoracic\\/upper\\:\\ 0\\.021602051179272747\ \(0\)\
\-\ wbc\\=32\\:\\ 0\\.021602051179272747\ \(0\)\
\-\ rbc\\=2\\:\\ 0\\.021602051179272747\ \(0\)\
\-\ glc\\=53\\:\\ 0\\.021602051179272747\ \(0\)\
\-\ prtn\\=92\\:\\ 0\\.021602051179272747\ \(0\)\
\-\ 5\\.68\\:\\ 0\\.021602051179272747\ \(0\)\
\-\ 10\\.6\\/31\\.6\\:\\ 0\\.021602051179272747\ \(0\)\
\-\ 443\\:\\ 0\\.021602051179272747\ \(0\)\
\-\ 140\\/4\\.4\\/99\\/29\\/11\\/0\\.5\\:\\ 0\\.021602051179272747\ \(0\)\
\-\ t10\\-t11\\:\\ 0\\.021602051179272747\ \(0\)\
\-\ citrobacter\\:\\ 0\\.021602051179272747\ \(0\)\
\-\ koseri\\:\\ 0\\.021602051179272747\ \(0\)\
\-\ truckdriver\\:\\ 0\\.021602051179272747\ \(0\)\
\-\ evalutaion\\:\\ 0\\.021602051179272747\ \(0\)\
\-\ unremarable\\:\\ 0\\.021602051179272747\ \(0\)\
\-\ \\-plain\\:\\ 0\\.020523686530048903\ \(0\)\
\-\ osteomyelitis\\/discitis\\:\\ 0\\.020523686530048903\ \(0\)\
\-\ h2o\\:\\ 0\\.019758574635230338\ \(0\)\
\-\ po4\\:\\ 0\\.019758574635230338\ \(0\)\
\-\ \\-on\\:\\ 0\\.019758574635230338\ \(0\)\
\-\ fat\\-suppressed\\:\\ 0\\.019758574635230338\ \(0\)\
\-\ high\\-signal\\:\\ 0\\.019758574635230338\ \(0\)\
\-\ discitis\\/osteomyelitis\\:\\ 0\\.019758574635230338\ \(0\)\
\-\ lumbar\\:\\ 0\\.019328376987629858\ \(0\)\
\-\ lymphs\\:\\ 0\\.01916510774343723\ \(0\)\
\-\ interfered\\:\\ 0\\.01916510774343723\ \(0\)\
\-\ duties\\:\\ 0\\.0186802099860065\ \(0\)\
\-\ stateside\\:\\ 0\\.0186802099860065\ \(0\)\
\-\ historically\\:\\ 0\\.0186802099860065\ \(0\)\
\-\ slower\\:\\ 0\\.018270234773699958\ \(0\)\
\-\ due\\:\\ 0\\.018193700688453506\ \(0\)\
\-\ \\:\\:\\ 0\\.018036300255170185\ \(0\)\
\-\ pmns\\:\\ 0\\.01791509809118793\ \(0\)\
\-\ 9\\.6\\:\\ 0\\.017601845336782655\ \(0\)\
\-\ \\<\\:\\ 0\\.0175429017420308\ \(0\)\
\-\ thoracic\\:\\ 0\\.017521582479277934\ \(0\)\
\-\ djd\\:\\ 0\\.01732163119939482\ \(0\)\
\-\ course\\:\\ 0\\.017151762997104476\ \(0\)\
\-\ fat\\-saturated\\:\\ 0\\.017068146678638638\ \(0\)\
\-\ prompting\\:\\ 0\\.01683673344196409\ \(0\)\
\-\ involvement\\:\\ 0\\.016659248173552216\ \(0\)\
\-\ 4\\.8\\:\\ 0\\.01662385390027915\ \(0\)\
\-\ intensity\\:\\ 0\\.01642909934244309\ \(0\)\
\-\ 94\\:\\ 0\\.016243266550170977\ \(0\)\
\-\ obtained\\:\\ 0\\.016158862237999158\ \(0\)\
\-\ brace\\:\\ 0\\.016071621547145525\ \(0\)\
\-\ lp\\:\\ 0\\.01591038585082522\ \(0\)\
\-\ \\%\\:\\ 0\\.015904157180952186\ \(0\)\
\-\ 96\\:\\ 0\\.01575836879274025\ \(0\)\
\-\ week\\:\\ 0\\.01543625222515015\ \(0\)\
\-\ medically\\:\\ 0\\.01534839358043371\ \(0\)\
\-\ evacuated\\:\\ 0\\.01522467013459623\ \(0\)\
\-\ fse\\:\\ 0\\.015106447361801459\ \(0\)\
\-\ \\'s\\:\\ 0\\.01503228684867323\ \(0\)\
\-\ deployed\\:\\ 0\\.014993256897921681\ \(0\)\
\-\ moves\\:\\ 0\\.014993256897921681\ \(0\)\
\-\ stir\\:\\ 0\\.014780377356236744\ \(0\)\
\-\ specificity\\:\\ 0\\.014780377356236744\ \(0\)\
\-\ cmp\\:\\ 0\\.014680004143516407\ \(0\)\
\-\ aa\\:\\ 0\\.014583281685615143\ \(0\)\
\-\ unclear\\:\\ 0\\.01448995370739368\ \(0\)\
\-\ diagnosing\\:\\ 0\\.01448995370739368\ \(0\)\
\-\ soldier\\:\\ 0\\.01431258303053551\ \(0\)\
\-\ 1\\.6\\:\\ 0\\.014228145003103114\ \(0\)\
\-\ method\\:\\ 0\\.014146305485372388\ \(0\)\
\-\ opening\\:\\ 0\\.01406690930678281\ \(0\)\
\-\ gram\\:\\ 0\\.01406690930678281\ \(0\)\
\-\ intramedullary\\:\\ 0\\.01406690930678281\ \(0\)\
\-\ stain\\:\\ 0\\.013989814793822032\ \(0\)\
\-\ puncture\\:\\ 0\\.013989814793822032\ \(0\)\
\-\ moving\\:\\ 0\\.013914892248697842\ \(0\)\
\-\ organisms\\:\\ 0\\.013771096447447107\ \(0\)\
\-\ t2wi\\:\\ 0\\.013634678111310004\ \(0\)\
\-\ ultimately\\:\\ 0\\.01326297081775905\ \(0\)\
\-\ his\\:\\ 0\\.013100473551313467\ \(0\)\
\-\ outpatient\\:\\ 0\\.012936900812194336\ \(0\)\
\-\ sat\\:\\ 0\\.012936900812194336\ \(0\)\
\-\ altered\\:\\ 0\\.012886240719187172\ \(0\)\
\-\ 76\\:\\ 0\\.012836527599473999\ \(0\)\
\-\ sensitivity\\:\\ 0\\.012836527599473999\ \(0\)\
\-\ 95\\:\\ 0\\.01278772669876071\ \(0\)\
\-\ contrast\\-enhanced\\:\\ 0\\.012739805141572736\ \(0\)\
\-\ against\\:\\ 0\\.012739805141572736\ \(0\)\
\-\ however\\:\\ 0\\.012656213061686544\ \(0\)\
\-\ worsened\\:\\ 0\\.012512352552641454\ \(0\)\
\-\ mg\\:\\ 0\\.012469106486493102\ \(0\)\
\-\ t1\\-weighted\\:\\ 0\\.012469106486493102\ \(0\)\
\-\ one\\:\\ 0\\.012317720123992787\ \(0\)\
\-\ disk\\:\\ 0\\.01230282894132998\ \(0\)\
\-\ 52\\:\\ 0\\.012108613156715912\ \(0\)\
\-\ signal\\:\\ 0\\.011984437926982864\ \(0\)\
\-\ anterior\\:\\ 0\\.011706344807248604\ \(0\)\
\-\ antibiotic\\:\\ 0\\.01162996587094729\ \(0\)\
\-\ t2\\-weighted\\:\\ 0\\.011507665037857337\ \(0\)\
\-\ metastatic\\:\\ 0\\.011442071295830266\ \(0\)\
\-\ suggests\\:\\ 0\\.01136229691940557\ \(0\)\
\-\ progression\\:\\ 0\\.011306303809836868\ \(0\)\
\-\ consistent\\:\\ 0\\.011145203557612783\ \(0\)\
\-\ disease\\:\\ 0\\.011144182509699766\ \(0\)\
\-\ 48\\:\\ 0\\.011119120839725698\ \(0\)\
\-\ enhance\\:\\ 0\\.010993051055431592\ \(0\)\
\-\ potential\\:\\ 0\\.010944250154718302\ \(0\)\
\-\ leading\\:\\ 0\\.01087268777993127\ \(0\)\
\-\ tuberculosis\\:\\ 0\\.010826027381923531\ \(0\)\
\-\ \\;\\:\\ 0\\.01077351695985422\ \(0\)\
\-\ recently\\:\\ 0\\.010604267783681376\ \(0\)\
\-\ mental\\:\\ 0\\.010604267783681376\ \(0\)\
\-\ ca\\:\\ 0\\.010583075843125053\ \(0\)\
\-\ was\\:\\ 0\\.010513590661847733\ \(0\)\
\-\ posterior\\:\\ 0\\.010476800790970471\ \(0\)\
\-\ diagnosis\\:\\ 0\\.010437336865853297\ \(0\)\
\-\ discharged\\:\\ 0\\.010419358042594645\ \(0\)\
\-\ evaluated\\:\\ 0\\.010419358042594645\ \(0\)\
\-\ incidence\\:\\ 0\\.010419358042594645\ \(0\)\
\-\ were\\:\\ 0\\.010320672003669793\ \(0\)\
\-\ cbc\\:\\ 0\\.010155069548410594\ \(0\)\
\-\ started\\:\\ 0\\.010137159888353828\ \(0\)\
\-\ until\\:\\ 0\\.009981179231222157\ \(0\)\
\-\ development\\:\\ 0\\.009898319742446106\ \(0\)\
\-\ 18\\:\\ 0\\.009865885505494462\ \(0\)\
\-\ underlying\\:\\ 0\\.009739964971991274\ \(0\)\
\-\ best\\:\\ 0\\.009561602656617483\ \(0\)\
\-\ involved\\:\\ 0\\.009533004806148701\ \(0\)\
\-\ condition\\:\\ 0\\.009504711193901212\ \(0\)\
\-\ csf\\:\\ 0\\.009490676467569181\ \(0\)\
\-\ specific\\:\\ 0\\.009394453976671569\ \(0\)\
\-\ \\,\\:\\ 0\\.009359656520544511\ \(0\)\
\-\ to\\:\\ 0\\.009086555498786942\ \(0\)\
\-\ seen\\:\\ 0\\.008982061782274947\ \(0\)\
\-\ 4\\.\\:\\ 0\\.008948085027661696\ \(0\)\
\-\ hours\\:\\ 0\\.008936694969704246\ \(0\)\
\-\ pressure\\:\\ 0\\.00892535348357005\ \(0\)\
\-\ rare\\:\\ 0\\.008825399464556639\ \(0\)\
\-\ developed\\:\\ 0\\.008750174161794452\ \(0\)\
\-\ cord\\:\\ 0\\.00863610085161011\ \(0\)\
\-\ pt\\:\\ 0\\.008449903602746682\ \(0\)\
\-\ later\\:\\ 0\\.008205900640938627\ \(0\)\
\-\ care\\:\\ 0\\.008197279646459448\ \(0\)\
\-\ spinal\\:\\ 0\\.00813770268717975\ \(0\)\
\-\ status\\:\\ 0\\.008112572662717163\ \(0\)\
\-\ then\\:\\ 0\\.008087677868143855\ \(0\)\
\-\ typically\\:\\ 0\\.008022408961452053\ \(0\)\
\-\ signs\\:\\ 0\\.007998340249962911\ \(0\)\
\-\ being\\:\\ 0\\.00791964887446957\ \(0\)\
\-\ presentation\\:\\ 0\\.007828193176837984\ \(0\)\
\-\ 3\\.\\:\\ 0\\.007776261202501934\ \(0\)\
\-\ less\\:\\ 0\\.0076966489476667085\ \(0\)\
\-\ cause\\:\\ 0\\.0076895282621062926\ \(0\)\
\-\ this\\:\\ 0\\.00766864797857021\ \(0\)\
\-\ areas\\:\\ 0\\.007647199923526773\ \(0\)\
\-\ palpation\\:\\ 0\\.007584944362627797\ \(0\)\
\-\ cases\\:\\ 0\\.007571305489311522\ \(0\)\
\-\ \\>\\:\\ 0\\.00755097743262916\ \(0\)\
\-\ spine\\:\\ 0\\.007484317941503584\ \(0\)\
\-\ cancer\\:\\ 0\\.007471184213736078\ \(0\)\
\-\ showed\\:\\ 0\\.007451604435967278\ \(0\)\
\-\ a\\:\\ 0\\.007383506948750555\ \(0\)\
\-\ revealed\\:\\ 0\\.007293813536877907\ \(0\)\
\-\ radiograph\\:\\ 0\\.0072392251434078795\ \(0\)\
\-\ 2\\.\\:\\ 0\\.00722724505797941\ \(0\)\
\-\ further\\:\\ 0\\.00722724505797941\ \(0\)\
\-\ mr\\:\\ 0\\.007221275191346899\ \(0\)\
\-\ differential\\:\\ 0\\.007215318695087579\ \(0\)\
\-\ between\\:\\ 0\\.007203445575064478\ \(0\)\
\-\ while\\:\\ 0\\.007150662871947642\ \(0\)\
\-\ 1\\.\\:\\ 0\\.00709890735717447\ \(0\)\
\-\ show\\:\\ 0\\.0069764785491798565\ \(0\)\
\-\ tenderness\\:\\ 0\\.006912000858727748\ \(0\)\
\-\ fat\\:\\ 0\\.006912000858727748\ \(0\)\
\-\ as\\:\\ 0\\.006875412265394297\ \(0\)\
\-\ month\\:\\ 0\\.006818123778725025\ \(0\)\
\-\ 6\\:\\ 0\\.006787553620677857\ \(0\)\
\-\ decreased\\:\\ 0\\.006757330858309998\ \(0\)\
\-\ level\\:\\ 0\\.006550236775656733\ \(0\)\
\-\ likely\\:\\ 0\\.006410345654084193\ \(0\)\
\-\ chronic\\:\\ 0\\.006401568172625\ \(0\)\
\-\ he\\:\\ 0\\.006340923782002712\ \(0\)\
\-\ y\\/o\\:\\ 0\\.006294226143137342\ \(0\)\
\-\ high\\:\\ 0\\.006219537396480892\ \(0\)\
\-\ cm\\:\\ 0\\.006095627972917515\ \(0\)\
\-\ lesions\\:\\ 0\\.0060839375168722015\ \(0\)\
\-\ therapy\\:\\ 0\\.006076172330427162\ \(0\)\
\-\ mild\\:\\ 0\\.0059847166327955765\ \(0\)\
\-\ who\\:\\ 0\\.005925447896653463\ \(0\)\
\-\ these\\:\\ 0\\.00591448056371766\ \(0\)\
\-\ prior\\:\\ 0\\.005835406309048839\ \(0\)\
\-\ over\\:\\ 0\\.005786283484414794\ \(0\)\
\-\ on\\:\\ 0\\.005775726162490117\ \(0\)\
\-\ bone\\:\\ 0\\.005647432663457101\ \(0\)\
\-\ increased\\:\\ 0\\.005559799951594829\ \(0\)\
\-\ pain\\:\\ 0\\.005551107274099652\ \(0\)\
\-\ the\\:\\ 0\\.00551526401743188\ \(0\)\
\-\ most\\:\\ 0\\.005246901972681053\ \(0\)\
\-\ present\\:\\ 0\\.005133002005137449\ \(0\)\
\-\ lower\\:\\ 0\\.005111335290861337\ \(0\)\
\-\ contrast\\:\\ 0\\.0050871693798082585\ \(0\)\
\-\ after\\:\\ 0\\.004702130858003198\ \(0\)\
\-\ patient\\:\\ 0\\.004556340058065893\ \(0\)\
\-\ in\\:\\ 0\\.004482949256811222\ \(0\)\
\-\ also\\:\\ 0\\.00448037125976104\ \(0\)\
\-\ images\\:\\ 0\\.0043597443934823244\ \(0\)\
\-\ within\\:\\ 0\\.004335455873367238\ \(0\)\
\-\ which\\:\\ 0\\.004242405817134438\ \(0\)\
\-\ male\\:\\ 0\\.004109589196509237\ \(0\)\
\-\ that\\:\\ 0\\.0039254806610607\ \(0\)\
\-\ for\\:\\ 0\\.0038782348332059313\ \(0\)\
\-\ of\\:\\ 0\\.003408355874409236\ \(0\)\
\-\ and\\:\\ 0\\.0033512314896955563\ \(0\)\
\-\ ct\\:\\ 0\\.003178999078170327\ \(0\)\
\-\ mass\\:\\ 0\\.0031608005503924587\ \(0\)\
\-\ an\\:\\ 0\\.00314272570288492\ \(0\)\
\-\ are\\:\\ 0\\.0030980688099191533\ \(0\)\
\-\ at\\:\\ 0\\.003079157321360726\ \(0\)\
\-\ is\\:\\ 0\\.0029909083956634343\ \(0\)\
\-\ or\\:\\ 0\\.002663624332350286\ \(0\)\
\-\ with\\:\\ 0\\.0024894505551040368\ \(0\)\
\-\ no\\:\\ 0\\.002288415294425005\ \(0\)\
\-\ \\(\\:\\ 0\\.0019211748038400545\ \(0\)\
\-\ \\)\\:\\ 0\\.0018977066279609177\ \(0\)\
\-\ \\.\\:\\ 0\\.0014162048975005163\ \(0\)\
